09. SAFETY METHODS IN PHARMACEUTICAL INDUSTRY:(a) Mechanical, chemical and fire hazards problems.(b) Inflammable gases and dusts.Note: STUDY TOUR:A visit to the pharmaceutical industries will be anintegral part of the syllabi and will prepare and submit a report aboutoperations in Pharmaceutical industry that will be evaluated in practicalexamination.PHARM 625 PHARMACEUTICS-X (Industrial <strong>Pharmacy</strong>-II) [Lab.]Cr. Hr.: 01 Marks: 50NOTE:- Practical of the subject shall be designed from time to time on the basis ofthe above mentioned theoretical topics and availability of the facilities,e.g. Manufacture of Tablets by Wet Granulation Method, by Slugging andby Direct Compression. Coating of Tablets (Sugar Coating, Filmcoatingand Enteric Coating). Clarification of liquids by various processes.Size Reduction. Homogenization. Ampoule filling, sealing andsterilization clarity and leakage tests in injectables. Capsule filling bysemi automatic machines. Manufacture of sustained action drugs. TabletsTests like Disintegration. Dissolution. Friability. Hardness and thicknesstests. Determination of weight variation in tablets. Density of powder.Particle size analysis.(Note: A minimum of 10 practical will be conducted)Recommended Books:1. Lachman, Theory and Practice of Industrial <strong>Pharmacy</strong>, 3 rd Ed,VerghesePublishing House, Bombay, 2009.2. Cooper and Gunn’s, Tutorial <strong>Pharmacy</strong>, 6 th Ed, CBS Publishers &Distributors, New Delhi, 2004.4. Bentley’s Pharmaceutical Text Book, CBS Publishers & Distributors, NewDelhi, 1986.5. Remington’s Pharmaceutical Sciences, 21 st Ed, Mack PublishingCompany, USA, 2005.6. John Sharp, Good Pharmaceutical Manufacturing Practice, 6 thEd,Rational and Compliance. 2009.PHARM 626 PHARMACEUTICS-XI (Biopharmaceutics-II) [Th.]Cr. Hr.: 03 Marks: 1001. MULTIPLE DOSAGE REGIMENa. Introduction, principles of superposition76 | Pakistan Pharmacist Federation; www.pharmacistfed.pk,www.pharmafed.wordpress.com, www.pharmarev.com, info@pharmacistfed.pk,
. Factors: persistent, accumulation and loss factorsc. Repetitive Intravenous injections – One Compartment Open Modeld. Repetitive Extravascular dosing – One Compartment Open modele. Multiple Dose Regimen – Two Compartment Open Model2. ELIMINATION OF DRUGS:a) Hepatic Elimination. Percent of Drug Metabolized, DrugBiotransformation reactions, (Phase-I reactions and phase-II reactions),First pass effect, Hepatic clearance of protein bound drugs and Biliaryexcretion of drugs.b) Renal Excretion of Drugs: Renal clearance, Tubular Secretion andTubular Reabsorption.c) Elimination of Drugs through other organs: Pulmonary excretion,Salivary excretion, Mammilary excretion, Skin excretion and Genitalexcretion.6. PROTEIN BINDING: Introduction, types, kinetics, determination andclinical significance of drug-protein binding.4. PHARMACOKINETICS VARIATIONS IN DISEASE STATES.Determination of pharmacokinetics variations in renal and hepatic diseases,general approaches for dose adjustment in renal diseaseand hepatic diseases.5. PHARMACOKINETICS OF INTRAVENOUS INFUSIONS.6. BIOPHARMACEUTICAL ASPECTS INDEVELOPING A DOSAGEFORMDrug considerations, drug product considerations, patient considerations,manufacturing considerations, pharmacodynamic considerationspharmacokinetic considerations7. IN-VITRO-IN-VIVO CORRELATION (IVIVC)Introduction, levels and determination of in-vitro/in-vivo correlationPHARM 627 PHARMACEUTICS-XI (Biopharmaceutics-II) [Lab.]Cr. Hr.: 01 Marks: 50NOTE:- Practical of the subject shall be designed from time to time on the basis ofthe above mentioned theoretical topics and availability of the facilities,e.g. Blood Sampling Techniques (In Laboratory Animals like dog,rabbits, mice etc. in human beings), In-vitro dissolution studies, Optionaldose determination, Measurement of rate of Bioavailability,Determination of relative and absolute bioavailability. Plasma level-timecurve (Determination of Pharmacokinetic parameters). Determination ofplasma protein binding. Urinary sampling techniques. In Laboratoryanimals. In humans. Renal excretion of drugs or drug disposition.Recommended Books:77 | Pakistan Pharmacist Federation; www.pharmacistfed.pk,www.pharmafed.wordpress.com, www.pharmarev.com, info@pharmacistfed.pk,
- Page 1 and 2:
NATIONAL CURRICULUM REVISIONCOMMITT
- Page 5 and 6:
The aims and objectives of Doctor o
- Page 7 and 8:
14. To prepare pharmacy graduates f
- Page 9 and 10:
and its Applications in Pharmacy)[L
- Page 11 and 12:
DETAILS OF COURSES ( SEMESTER SYSTE
- Page 13 and 14:
PHARM 311 PHARMACEUTICS-I (Physical
- Page 15 and 16:
9. Naser-ud-Din, Introduction to St
- Page 17 and 18:
Expression of Genetic Information,
- Page 19 and 20:
2. STRUCTURE OF CELL: Cell Membrane
- Page 21 and 22:
Communications SkillsObjectives: En
- Page 23 and 24:
Experiments to demonstrate some of
- Page 25 and 26: 1990.9. Naser-ud-Din, Introduction
- Page 27 and 28: Hemorrhage and Other Causes of Hypo
- Page 29 and 30: IS 402ISLAMIC STUDIESCr. Hr.: 01 Ma
- Page 31 and 32: Publications New Delhi (1989)9) Dr.
- Page 33 and 34: PHARM 413 PHARMACEUTICS-V (Pharmace
- Page 35 and 36: e. Drug treatment of chronic inflam
- Page 37 and 38: j. Labiatae Peppermint, Thyme, Spea
- Page 39 and 40: SECOND SEMESTERPS 403PAKISTAN STUDI
- Page 41 and 42: NOTE:- Practicals of the subject sh
- Page 43 and 44: i. Drugs used for cough (Anti-tussi
- Page 45 and 46: 1. Drugs of Animal OriginGeneral in
- Page 47 and 48: Frequency Table, Diagrams, Pictogra
- Page 49 and 50: pharmaceutical students Churchill L
- Page 51 and 52: anaesthetic drugs on human and the
- Page 53 and 54: 5. Plant SteroidsIntroduction, extr
- Page 55 and 56: Adenoma, Chondroma, Fibroma, Leomyo
- Page 57 and 58: Aluminium Hydroxide, Ammonium Chlor
- Page 59 and 60: of frog. To demonstrate the effects
- Page 61 and 62: 6. Tumor Inhibitors from PlantsIntr
- Page 63 and 64: • Components of a Computer• Com
- Page 65 and 66: 1. INTRODUCTION(a) Role of Pharmaci
- Page 67 and 68: withdrawal, Detection, Management o
- Page 69 and 70: (Note: A minimum of 10 practicals w
- Page 71 and 72: 14. Ronald D Schoenwald, Pharmacoki
- Page 73 and 74: Distribution, Relationship between
- Page 75: 4. A J Winfield, Pharmaceutical Pra
- Page 79 and 80: vaccines.5. MISCELLANEOUS DETERMINA
- Page 81 and 82: 3. T V Ramabhadran, Pharmaceutical
- Page 83 and 84: 1. R Z Hussain, The Manual of Drug
- Page 85 and 86: NOTE:- Practical of the subject sha
- Page 87 and 88: PHARM 722 PHARMACY PRACTICE-XIII (C
- Page 89 and 90: 3. The Pharmacy Act 1967.4. The Poi
- Page 91 and 92: 6. Block, Roche, Soine and Wilson.
- Page 93 and 94: PHARM-D FIVE-YEAR COURSESCHEME OF S
- Page 95 and 96: Paper 4 Pharmacy Practice -VI (Fore
- Page 97 and 98: 9. PREPARATION AND PROPERTIES OF HE
- Page 99 and 100: c. Proteins and Amino acids: Brief
- Page 101 and 102: 3. PHYSICO-CHEMICAL PRINCIPLES:a. S
- Page 103 and 104: 2. Cooper and Gunns Tutorial Pharma
- Page 105 and 106: Experiences, Motivation and Emotion
- Page 107 and 108: 5. CENTRAL NERVOUS SYSTEM: Nerve Mu
- Page 109 and 110: (b)Spinal Cord — Meninges (C.S.F.
- Page 111 and 112: 1. DESCRIPTION OF STATISTICS: Descr
- Page 113 and 114: Part: B, (Communications Skills)Obj
- Page 115 and 116: 1. Writing. Advanced by Ron White.
- Page 117 and 118: effervescent, granulated salts. Har
- Page 119 and 120: Parasympathetic antagonists.f. Gang
- Page 121 and 122: (Note: A minimum of 20 practicals w
- Page 123 and 124: Sources, structure, preparation, de
- Page 125 and 126: Microbiology with special reference
- Page 127 and 128:
Objectives• Develop vision of his
- Page 129 and 130:
2 To enhance understanding of the s
- Page 131 and 132:
1) Basic Concepts of Islam & Scienc
- Page 133 and 134:
Chondroma, Fibroma, Leomyoma, Neofi
- Page 135 and 136:
Note:(a)(b)(c)(d)Pollution and its
- Page 137 and 138:
14. Pharmacology by Ran & Dell, 6 t
- Page 139 and 140:
(e) Phenolic volatile oils: Clove,
- Page 141 and 142:
their identification. Isolation and
- Page 143 and 144:
6. ROLE OF PHARMACIST: As Public He
- Page 145 and 146:
d. I.R. Spectroscopye. Mass Spectro
- Page 147 and 148:
F O U R T H P R O F E S S I O N A L
- Page 149 and 150:
16. NUCLEAR PHARMACY.17. THE PHYSIC
- Page 151 and 152:
I. Ensure continuity of pharmaceuti
- Page 153 and 154:
1. MASS TRANSFER.2. HEAT TRANSFER.3
- Page 155 and 156:
Delhi, 1986.4. Remington’s Pharma
- Page 157 and 158:
14. IN-VITRO-IN-VIVO CORRELATION (I
- Page 159 and 160:
5. QUALITY CONTROL OF STERILE PRODU
- Page 161 and 162:
F I N A L P R O F E S S I O N A LPH
- Page 163 and 164:
3. Tyagi, Textbook of Synthetic Dru
- Page 165 and 166:
Horwood Publishing limited, West Su
- Page 167 and 168:
NOTE:- Practical of the subject sha
- Page 169 and 170:
3. The Pharmacy Act 1967.4. The Poi
- Page 171 and 172:
5. Application of Computers in Hosp
- Page 173:
RecommendationsAll members of NCRC